BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32487782)

  • 1. Topical Application of S1P
    Kang J; Lee JH; Im DS
    Biomol Ther (Seoul); 2020 Nov; 28(6):537-541. PubMed ID: 32487782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockage of sphingosine-1-phosphate receptor 2 attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice.
    Park SJ; Im DS
    Acta Pharmacol Sin; 2020 Nov; 41(11):1487-1496. PubMed ID: 32457418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Honokiol suppresses 2,6-dinitrochlorobenzene-induced atopic dermatitis in mice.
    Lee JH; Im DS
    J Ethnopharmacol; 2022 May; 289():115023. PubMed ID: 35074454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artesunate attenuates 2, 4-dinitrochlorobenzene-induced atopic dermatitis by down-regulating Th17 cell responses in BALB/c mice.
    Bai XY; Liu P; Chai YW; Wang Y; Ren SH; Li YY; Zhou H
    Eur J Pharmacol; 2020 May; 874():173020. PubMed ID: 32087254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclareol attenuates the development of atopic dermatitis induced by 2,4-dinitrochlorobenzene in mice.
    Wu PC; Chuo WH; Lin SC; Lehman CW; Lien CZ; Wu CS; Lin CC
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):109-116. PubMed ID: 30704333
    [No Abstract]   [Full Text] [Related]  

  • 6. Free fatty acid receptor 4 (FFA4) activation ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis by increasing regulatory T cells in mice.
    Son SE; Park SJ; Koh JM; Im DS
    Acta Pharmacol Sin; 2020 Oct; 41(10):1337-1347. PubMed ID: 32555509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FFA2 Activation Ameliorates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis in Mice.
    Kang J; Im DS
    Biomol Ther (Seoul); 2020 May; 28(3):267-271. PubMed ID: 32279475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents.
    Tanimoto A; Shinozaki Y; Yamamoto Y; Katsuda Y; Taniai-Riya E; Toyoda K; Kakimoto K; Kimoto Y; Amano W; Konishi N; Hayashi M
    Exp Dermatol; 2018 Jan; 27(1):22-29. PubMed ID: 28423239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (R)-(+)-pulegone suppresses allergic and inflammation responses on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice model.
    Choi YY; Kim MH; Lee H; Jo SY; Yang WM
    J Dermatol Sci; 2018 Sep; 91(3):292-300. PubMed ID: 29933898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rutin suppresses atopic dermatitis and allergic contact dermatitis.
    Choi JK; Kim SH
    Exp Biol Med (Maywood); 2013 Apr; 238(4):410-7. PubMed ID: 23760007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis.
    Hwang JS; Kim JE; Kim HT; Yu YB; Im SH
    J Ethnopharmacol; 2013 Jan; 145(2):536-46. PubMed ID: 23211659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of herbal mixture extract inhibits ovalbumin- or 2,4-dinitrochlorobenzene-induced atopic dermatitis.
    Kim SR; Choi HS; Seo HS; Choi YK; Shin YC; Ko SG
    Evid Based Complement Alternat Med; 2012; 2012():545497. PubMed ID: 23304205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elemol from Chamaecyparis obtusa ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis.
    Yang H; Jung EM; Ahn C; Lee GS; Lee SY; Kim SH; Choi IG; Park MJ; Lee SS; Choi DH; Jeung EB
    Int J Mol Med; 2015 Aug; 36(2):463-72. PubMed ID: 26035417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of atopic dermatitis with topical application of Spirodela polyrhiza.
    Lee HJ; Kim MH; Choi YY; Kim EH; Hong J; Kim K; Yang WM
    J Ethnopharmacol; 2016 Mar; 180():12-7. PubMed ID: 26778605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of galangin on atopic dermatitis-like skin lesions.
    Choi JK; Kim SH
    Food Chem Toxicol; 2014 Jun; 68():135-41. PubMed ID: 24675422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External application of NF-κB inhibitor DHMEQ suppresses development of atopic dermatitis-like lesions induced with DNCB/OX in BALB/c mice.
    Jiang X; Lan Y; Wei B; Dai C; Gu Y; Ma J; Liu X; Umezawa K; Zhang Y
    Immunopharmacol Immunotoxicol; 2017 Jun; 39(3):157-164. PubMed ID: 28418286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sceptridium ternatum attenuates allergic contact dermatitis-like skin lesions by inhibiting T helper 2-type immune responses and inflammatory responses in a mouse model.
    Lim D; Kim MK; Jang YP; Kim J
    J Dermatol Sci; 2015 Sep; 79(3):288-97. PubMed ID: 26150208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory and immune response regulation of Si-Ni-San in 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin dysfunction.
    Fan HJ; Xie ZP; Lu ZW; Tan ZB; Bi YM; Xie LP; Wu YT; Zhang WT; Liu-Kot K; Liu B; Zhou YC
    J Ethnopharmacol; 2018 Aug; 222():1-10. PubMed ID: 29698775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chamaejasmine Isolated from
    Kim TY; Park NJ; Jegal J; Choi S; Lee SW; Hang J; Kim SN; Yang MH
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31694198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DA-9601 suppresses 2, 4-dinitrochlorobenzene and dust mite extract-induced atopic dermatitis-like skin lesions.
    Choi EJ; Lee S; Hwang JS; Im SH; Jun CD; Lee HS; Kim SH
    Int Immunopharmacol; 2011 Sep; 11(9):1260-4. PubMed ID: 21511060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.